Muhammad Mamdani

MPH, MA, PharmD

Director, Li Ka Shing Centre for Healthcare Analytics Research and Training (CHART)


Dr. Mamdani is the Director of the Li Ka Shing Centre for Healthcare Analytics Research and Training (CHART) of the Li Ka Shing Knowledge Institute of St. Michael’s Hospital in Toronto. He is also Professor in the Leslie Dan Faculty of Pharmacy, the Department of Medicine of the Faculty of Medicine, and the Institute of Health Policy, Management and Evaluation of the Dalla Lana Faculty of Public Health. He is also adjunct Senior Scientist at the Institute for Clinical Evaluative Sciences (ICES). Dr. Mamdani also is a member of the Human Drug Advisory Panel of the Patented Medicine Prices Review Board (PMPRB) and is a co-Principal Investigator of the Ontario Drug Policy Research Network. In 2010, Dr. Mamdani was named among Canada’s Top 40 under 40. Prior to joining the Li Ka Shing Knowledge Institute and St. Michael’s Hospital, Dr. Mamdani was a Director of Outcomes Research at Pfizer Global Pharmaceuticals in New York. Dr. Mamdani’s research interests include pharmacoepidemiology, pharmacoeconomics, and drug policy. He has published approximately 350 research studies in peer-reviewed medical journals, including leading journals such as the New England Journal of Medicine, the Lancet, the Journal of the American Medical Association, the British Medical Journal, and Annals of Internal Medicine.

Dr. Mamdani obtained a Doctor of Pharmacy degree (PharmD) from the University of Michigan (Ann Arbor) in 1995 and subsequently completed a fellowship in pharmacoeconomics and outcomes research at the Detroit Medical Center in 1997. During his fellowship, Dr. Mamdani obtained a Master of Arts degree in Economics from Wayne State University in Detroit, Michigan. He then completed a Master of Public Health degree from Harvard University in 1998 with a concentration in quantitative methods, focusing on biostatistics and epidemiological principles.

Please note: Dr. Mamdani is not taking any summer students.




Recent Publications

  1. Li, X, Keown-Stoneman, CDG, Lebovic, G, Omand, JA, Adeli, K, Hamilton, JK et al.. The association between body mass index trajectories and cardiometabolic risk in young children. Pediatr Obes. 2020; :e12633. doi: 10.1111/ijpo.12633. PubMed PMID:32181602 .
  2. Salata, K, Hussain, MA, de Mestral, C, Greco, E, Awartani, H, Aljabri, BA et al.. Population-based long-term outcomes of open versus endovascular aortic repair of ruptured abdominal aortic aneurysms. J. Vasc. Surg. 2020; :. doi: 10.1016/j.jvs.2019.06.212. PubMed PMID:32085959 .
  3. Livingston, MH, Mahant, S, Connolly, B, MacLusky, I, Laberge, S, Giglia, L et al.. Effectiveness of Intrapleural Tissue Plasminogen Activator and Dornase Alfa vs Tissue Plasminogen Activator Alone in Children with Pleural Empyema: A Randomized Clinical Trial. JAMA Pediatr. 2020; :. doi: 10.1001/jamapediatrics.2019.5863. PubMed PMID:32011642 PubMed Central PMC7042898.
  4. Martins, D, McCormack, D, Tadrous, M, Gomes, T, Kwong, JC, Mamdani, MM et al.. Impact of a publicly funded herpes zoster immunization program on the burden of disease in Ontario, Canada: a population-based study. Clin. Infect. Dis. 2020; :. doi: 10.1093/cid/ciaa014. PubMed PMID:31922540 .
  5. Chung, F, Wong, J, Bellingham, G, Lebovic, G, Singh, M, Waseem, R et al.. Predictive factors for sleep apnoea in patients on opioids for chronic pain. BMJ Open Respir Res. 2019;6 (1):e000523. doi: 10.1136/bmjresp-2019-000523. PubMed PMID:31908788 PubMed Central PMC6936992.
  6. Tadrous, M, Knowles, S, Ruddock, B, Oh, P, Mamdani, MM, Juurlink, DN et al.. Comprehensive Drug-Class Review Framework for improved evidence-based drug policy and formulary modernization. Int J Technol Assess Health Care. 2019; :1-8. doi: 10.1017/S0266462319000746. PubMed PMID:31796132 .
  7. Birken, CS, Omand, JA, Nurse, KM, Borkhoff, CM, Koroshegyi, C, Lebovic, G et al.. Fit for School Study protocol: early child growth, health behaviours, nutrition, cardiometabolic risk and developmental determinants of a child's school readiness, a prospective cohort. BMJ Open. 2019;9 (11):e030709. doi: 10.1136/bmjopen-2019-030709. PubMed PMID:31748293 PubMed Central PMC6886995.
  8. Kaw, N, Murray, J, Lopez, AJ, Mamdani, MM. Nursing resource team capacity planning using forecasting and optimization methods: A case study. J Nurs Manag. 2019; :. doi: 10.1111/jonm.12905. PubMed PMID:31733153 .
  9. Petch, J, Batt, J, Murray, J, Mamdani, M. Extracting Clinical Features From Dictated Ambulatory Consult Notes Using a Commercially Available Natural Language Processing Tool: Pilot, Retrospective, Cross-Sectional Validation Study. JMIR Med Inform. 2019;7 (4):e12575. doi: 10.2196/12575. PubMed PMID:31682579 PubMed Central PMC6913750.
  10. Mamdani, M, Gomes, T, Greaves, S, Manji, S, Juurlink, DN, Tadrous, M et al.. Association Between Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, and Suicide. JAMA Netw Open. 2019;2 (10):e1913304. doi: 10.1001/jamanetworkopen.2019.13304. PubMed PMID:31617924 PubMed Central PMC6806420.
Search PubMed

Affiliations & Other Activities

  • Scientist, Li Ka Shing Knowledge Institute, St. Michael’s Hospital
  • Professor, Institute of Health Policy, Management, and Evaluation, University of Toronto
  • Professor, Leslie Dan Faculty of Pharmacy, University of Toronto
  • Adjunct Professor, King Saud University Senior Adjunct
  • Scientist, Institute for Clinical Evaluative Sciences